KIRLOSELEC

Envair Electrodyne Share Price

 

 

Start SIP in KIRLOSELEC

Start SIP

Performance

  • Low
  • ₹76
  • High
  • ₹77
  • 52 Week Low
  • ₹68
  • 52 Week High
  • ₹154
  • Open Price₹77
  • Previous Close₹77
  • Volume118

Investment Returns

  • Over 1 Month -14.64%
  • Over 3 Month + 3.25%
  • Over 6 Month -35.55%
  • Over 1 Year -46.36%

Smart Investing Starts Here Start SIP with Envair Electrodyne for Steady Growth!

Invest Now

Envair Electrodyne Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -55.6
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 36
  • P/B Ratio
  • 4.3
  • Average True Range
  • 5.38
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.33
  • RSI
  • 42.17
  • MFI
  • 8.08

Envair Electrodyne Financials

Envair Electrodyne Technicals

EMA & SMA

Current Price
₹76.49
-0.5 (-0.65%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹82.54
  • 50 Day
  • ₹82.37
  • 100 Day
  • ₹84.79
  • 200 Day
  • ₹96.26

Resistance and Support

76.37 Pivot Speed
  • R3 82.48
  • R2 80.24
  • R1 78.61
  • S1 74.74
  • S2 72.50
  • S3 70.87

Envair Electrodyne Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-26 Audited Results
2025-02-10 Quarterly Results
2024-11-12 Quarterly Results

Envair Electrodyne F&O

Envair Electrodyne Shareholding Pattern

No data available.

Envair Electrodyne FAQs

Envair Electrodyne share price is ₹76 As on 17 November, 2025 | 17:45

The Market Cap of Envair Electrodyne is ₹35.5 Cr As on 17 November, 2025 | 17:45

The P/E ratio of Envair Electrodyne is -55.6 As on 17 November, 2025 | 17:45

The PB ratio of Envair Electrodyne is 4.3 As on 17 November, 2025 | 17:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23